Courtney Kiss

Courtney Kiss

Auto-generated profile, based on publicly available information

Courtney Kiss

Division of Medical Genetics, Department of Pediatrics Queen's University Kingston Ontario Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
SDStephanie M. Dobson
Stephanie M. Dobson
CKCourtney Kiss
Courtney Kiss
DBDaniel BORSCHNECK
Daniel BORSCHNECK
KHKaren E. Heath
Karen E. Heath
AGAdrian Gross
Adrian Gross
AGAndrea Guerin
Andrea Guerin

21 September 2016 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
SASarah Abdullah
Sarah Abdullah
WRWilliam Reginold
William Reginold
CKCourtney Kiss
Courtney Kiss
KHKaren J. Harrison
Karen J. Harrison
JMJennifer J. MacKenzie
Jennifer J. MacKenzie
Childhood obesity is a growing health concern, associated with significant physical and psychological morbidity. Childhood obesity is known to have a strong genetic component, with mutations in themelanocortin-4 receptor(MC4R) gene being the most common monogenetic cause of obesity. Over 166 differentMC4Rmutations have been identified in persons with hyperphagia, severe childhood obesity, and increased linear growth. However, it is unclear whether the MC4-R deficiency phenotype is due to haploinsufficiency or dominant-negative effects by the mutant receptor. We report the case of a four-and-a-half-year-old boy with an interstitial deletion involving the long arm of chromosome 18 (46,XY,del(18)(q21.32q22.1)) encompassing theMC4Rgene. This patient presented with tall stature and hyperphagia within his first 18 months of life leading to significant obesity. This case supports haploinsufficiency of MC4-R as it describes a MC4-R deficiency phenotype in a patient heterozygous for a fullMC4Rgene deletion. The intact functional allele with MC4-R haploinsufficiency has the potential to favor a therapeutic response to gastric surgery. Currently, small molecule MC4-R agonists are under development for pharmacologic therapy.